HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

teopranitol

Also Known As:

KC 046; KC-046

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Coronary Disease (Coronary Heart Disease) 06/01/1984 - "It is concluded from these results that the clinical improvement of the patients with coronary heart disease treated by KC 046 is caused by a significant shift of blood volume from the thoracic region into the abdomen and the legs, thus decreasing the preload of the left ventricle." 06/01/1984 - "To evaluate the effects of the new compound teopranitol (KC 046) on blood volume distribution scintigraphic measurements were performed in 10 patients with coronary heart disease. "
2.	Body Weight (Weight, Body) 06/01/1984 - "The differences in blood volume distribution were calculated by the ratio of the impulse rates thorax/abdomen, thorax/thigh, thorax/shank and heart/total impulse rates assessed by scintigraphy, following in vivo labeling of red blood cells with 99m-Tc, before and after i.v. injection of 0.04 mg KC 046/kg body weight. "

Related Drugs and Biologics

1.	teopranitol